Follow-Up Mastermind Session: Translational Readiness Challenge

Working in small groups, attendees will assess a hypothetical radiopharmaceutical program preparing for first-in-human studies and determine whether it is truly ready to progress into the clinic

• Identifying the critical scientific, preclinical, CMC, and regulatory evidence still required before IND submission
• Prioritizing the highest-risk translational gaps that could delay clinical entry or reduce investor confidence
• Developing a practical action plan to strengthen the data package and accelerate progression into first-in-human studies